Exercise alters mRNA expression of telomere-repeat binding factor 1 in skeletal muscle via p38 MAPK

Journal of Applied Physiology

Volumn 113, Issue 11, 2012, Pages 1737-1746

  Ludlow, Andrew T ^a   Lima, Laila C J ^a,b   Wang, Jenny ^a   Hanson, Erik D ^a   Guth, Lisa M ^a   Spangenburg, Espen E ^a   Roth, Stephen M ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

Author keywords

Gene expression; Shelterin; Signaling; Telomeres; Treadmill exercise

Indexed keywords

CALCIMYCIN; CALCIUM; CALCIUM IONOPHORE; DNA BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; POT1 PROTEIN, MOUSE; POT1B PROTEIN, MOUSE; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; TRF2 PROTEIN, MOUSE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL LINE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; EXERCISE; FEMALE; GENETICS; METABOLISM; MOUSE; MUSCLE CONTRACTION; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TIME;

ANIMALS; CALCIMYCIN; CALCIUM; CALCIUM IONOPHORES; CELL LINE; DNA-BINDING PROTEINS; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PHYSICAL EXERTION; RNA, MESSENGER; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2; TIME FACTORS;

EID: 84870434444     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00200.2012     Document Type: Article

References (49)

1. Aguennouz M, Vita GL, Messina S, Cama A, Lanzano N, Ciranni A, Rodolico C, Di Giorgio RM, Vita G. Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy. Neurobiol Aging 32: 2190-2197, 2011.
2. Akimoto T, Pohnert SC, Li P, Zhang M, Gumbs C, Rosenberg PB, Williams RS, Yan Z. Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem 280: 19587-19593, 2005.
3. Allen DL, Leinwand LA. Intracellular calcium and myosin isoform transitions. Calcineurin and calcium-calmodulin kinase pathways regulate preferential activation of the IIa myosin heavy chain promoter. J Biol Chem 277: 45323-45330, 2002.
4. Allen DL, Uyenishi JJ, Cleary AS, Mehan RS, Lindsay SF, Reed JM. Calcineurin activates interleukin-6 transcription in mouse skeletal muscle in vivo and in C2C12 myotubes in vitro. Am J Physiol Regul Integr Comp Physiol 298: R198-R210, 2010.
5. Blackburn EH. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett 579: 859-862, 2005.
6. Blasco MA. Telomere length, stem cells and aging. Nat Chem Biol 3: 640-649, 2007.
7. Chambers MA, Moylan JS, Smith JD, Goodyear LJ, Reid MB. Stretch-stimulated glucose uptake in skeletal muscle is mediated by reactive oxygen species and p38 MAP-kinase. J Physiol 587: 3363-3373, 2009.
8. Cherkas LF, Hunkin JL, Kato BS, Richards JB, Gardner JP, Surdulescu GL, Kimura M, Lu X, Spector TD, Aviv A. The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med 168: 154-158, 2008.
9. Chin ER, Balnave CD, Allen DG. Role of intracellular calcium and metabolites in low-frequency fatigue of mouse skeletal muscle. Am J Physiol Cell Physiol 272: C550-C559, 1997.
10. Collins M, Renault V, Grobler LA, St. Clair Gibson A, Lambert MI, Wayne Derman E, Butler-Browne GS, Noakes TD, Mouly V. Athletes with exercise-associated fatigue have abnormally short muscle DNA telomeres. Med Sci Sports Exerc 35: 1524-1528, 2003.
11. de Lange T. How shelterin solves the telomere end-protection problem. Cold Spring Harb Symp Quant Biol 75: 167-177, 2010.
12. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19: 2100-2110, 2005.
13. Decary S, Mouly V, Hamida CB, Sautet A, Barbet JP, Butler-Browne GS. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum Gene Ther 8: 1429-1438, 1997.
14. Du M, Prescott J, Kraft P, Han J, Giovannucci E, Hankinson SE, De Vivo I. Physical activity, sedentary behavior, and leukocyte telomere length in women. Am J Epidemiol 175: 414-422, 2012.
15. English JM, Cobb MH. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 23: 40-45, 2002.
16. Freyssenet D, Di Carlo M, Hood DA. Calcium-dependent regulation of cytochrome c gene expression in skeletal muscle cells. Identification of a protein kinase c-dependent pathway. J Biol Chem 274: 9305-9311, 1999.
17. Freyssenet D, Irrcher I, Connor MK, Di Carlo M, Hood DA. Calciumregulated changes in mitochondrial phenotype in skeletal muscle cells. Am J Physiol Cell Physiol 286: C1053-C1061, 2004.
18. Geiger PC, Wright DC, Han DH, Holloszy JO. Activation of p38 MAP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab 288: E782-E788, 2005.
19. Ghosh A, Rossi ML, Aulds J, Croteau D, Bohr VA. Telomeric D-loops containing 8-oxo-2=-deoxyguanosine are preferred substrates for Werner and Bloom syndrome helicases and are bound by POT1. J Biol Chem 284: 31074-31084, 2009.
20. Greider CW. Telomerase RNA levels limit the telomere length equilibrium. Cold Spring Harb Symp Quant Biol 71: 225-229, 2006.
21. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T. Mammalian telomeres end in a large duplex loop. Cell 97: 503-514, 1999.
22. Hockemeyer D, Daniels JP, Takai H, de Lange T. Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres. Cell 126: 63-77, 2006.
23. Irrcher I, Adhihetty PJ, Sheehan T, Joseph AM, Hood DA. PPARγ coactivator-1α expression during thyroid hormone-and contractile activity-induced mitochondrial adaptations. Am J Physiol Cell Physiol 284: C1669-C1677, 2003.
24. Kadi F, Ponsot E, Piehl-Aulin K, Mackey A, Kjaer M, Oskarsson E, Holm L. The effects of regular strength training on telomere length in human skeletal muscle. Med Sci Sports Exerc 40: 82-87, 2008.
25. Karlseder J, Kachatrian L, Takai H, Mercer K, Hingorani S, Jacks T, de Lange T. Targeted deletion reveals an essential function for the telomere length regulator Trf1. Mol Cell Biol 23: 6533-6541, 2003.
26. Laye MJ, Solomon TP, Karstoft K, Pedersen KK, Nielsen SD, Klarlund Pedersen B. Increased shelterin mRNA expression in peripheral blood mononuclear cells and skeletal muscle following an ultra-longdistance running event. J Appl Physiol 112: 773-781, 2012.
27. Leick L, Wojtaszewski JF, Johansen ST, Kiilerich K, Comes G, Hellsten Y, Hidalgo J, Pilegaard H. PGC-1α is not mandatory for exercise-and training-induced adaptive gene responses in mouse skeletal muscle. Am J Physiol Endocrinol Metab 294: E463-E474, 2008.
28. Ludlow AT, Roth SM. Physical activity and telomere biology: exploring the link with aging-related disease prevention. J Aging Res 2011: 790378, 2011.
29. Ludlow AT, Witkowski S, Marshall MR, Wang J, Lima CJ, Guth LM, Spangenburg EE, Roth SM. Chronic exercise modifies age-related telomere dynamics in a tissue-specific fashion. J Gerontol A Biol Sci Med Sci 67: 911-926, 2012.
30. Ludlow AT, Zimmerman JB, Witkowski S, Hearn JW, Hatfield BD, Roth SM. Relationship between physical activity level, telomere length, and telomerase activity. Med Sci Sports Exerc 40: 1764-1771, 2008.
31. Martinez P, Thanasoula M, Carlos AR, Gomez-Lopez G, Tejera AM, Schoeftner S, Dominguez O, Pisano DG, Tarsounas M, Blasco MA. Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat Cell Biol 12: 768-780, 2010.
32. Martinez P, Thanasoula M, Munoz P, Liao C, Tejera A, McNees C, Flores JM, Fernandez-Capetillo O, Tarsounas M, Blasco MA. Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev 23: 2060-2075, 2009.
33. McClung JM, Judge AR, Powers SK, Yan Z. p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting. Am J Physiol Cell Physiol 298: C542-C549, 2010.
34. Munoz P, Blanco R, de Carcer G, Schoeftner S, Benetti R, Flores JM, Malumbres M, Blasco MA. TRF1 controls telomere length and mitotic fidelity in epithelial homeostasis. Mol Cell Biol 29: 1608-1625, 2009.
35. Ojuka EO, Jones TE, Han DH, Chen M, Holloszy JO. Raising Ca2+ in L6 myotubes mimics effects of exercise on mitochondrial biogenesis in muscle. FASEB J 17: 675-681, 2003.
36. Ojuka EO, Jones TE, Han DH, Chen M, Wamhoff BR, Sturek M, Holloszy JO. Intermittent increases in cytosolic Ca2+ stimulate mitochondrial biogenesis in muscle cells. Am J Physiol Endocrinol Metab 283: E1040-E1045, 2002.
37. Ponsot E, Echaniz-Laguna A, Delis AM, Kadi F. Telomere length and regulatory proteins in human skeletal muscle with and without ongoing regenerative cycles. Exp Physiol 97: 774-784, 2012.
38. Rae DE, Vignaud A, Butler-Browne GS, Thornell LE, Sinclair-Smith C, Derman EW, Lambert MI, Collins M. Skeletal muscle telomere length in healthy, experienced, endurance runners. Eur J Appl Physiol 109: 323-330, 2010.
39. Renault V, Thornell LE, Eriksson PO, Butler-Browne G, Mouly V. Regenerative potential of human skeletal muscle during aging. Aging Cell 1: 132-139, 2002.
40. Rockl KS, Witczak CA, Goodyear LJ. Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise. IUBMB Life 60: 145-153, 2008.
41. Roy RR, Hutchison DL, Pierotti DJ, Hodgson JA, Edgerton VR. EMG patterns of rat ankle extensors and flexors during treadmill locomotion and swimming. J Appl Physiol 70: 2522-2529, 1991.
42. Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, de Lange T. Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20: 1659-1668, 2000.
43. Spallarossa P, Altieri P, Aloi C, Garibaldi S, Barisione C, Ghigliotti G, Fugazza G, Barsotti A, Brunelli C. Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2. Am J Physiol Heart Circ Physiol 297: H2169-H2181, 2009.
44. Spangenburg EE, Brown DA, Johnson MS, Moore RL. Alterations in peroxisome proliferator-activated receptor mRNA expression in skeletal muscle after acute and repeated bouts of exercise. Mol Cell Biochem 332: 225-231, 2009.
45. Werner C, Furster T, Widmann T, Poss J, Roggia C, Hanhoun M, Scharhag J, Buchner N, Meyer T, Kindermann W, Haendeler J, Bohm M, Laufs U. Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation 120: 2438-2447, 2009.
46. Werner C, Hanhoun M, Widmann T, Kazakov A, Semenov A, Poss J, Bauersachs J, Thum T, Pfreundschuh M, Muller P, Haendeler J, Bohm M, Laufs U. Effects of physical exercise on myocardial telomereregulating proteins, survival pathways, and apoptosis. J Am Coll Cardiol 52: 470-482, 2008.
47. Wohlers LM, Sweeney SM, Ward CW, Lovering RM, Spangenburg EE. Changes in contraction-induced phosphorylation of AMP-activated protein kinase and mitogen-activated protein kinases in skeletal muscle after ovariectomy. J Cell Biochem 107: 171-178, 2009.
48. Wright DC, Geiger PC, Han DH, Jones TE, Holloszy JO. Calcium induces increases in peroxisome proliferator-activated receptor gamma coactivator-1alpha and mitochondrial biogenesis by a pathway leading to p38 mitogen-activated protein kinase activation. J Biol Chem 282: 18793-18799, 2007.
49. Wu H, Rothermel B, Kanatous S, Rosenberg P, Naya FJ, Shelton JM, Hutcheson KA, DiMaio JM, Olson EN, Bassel-Duby R, Williams RS. Activation of MEF2 by muscle activity is mediated through a calcineurindependent pathway. EMBO J 20: 6414-6423, 2001.